In vitro and In vivo safety assessment of AgNPs-silica to be applied in animal feed as an alternative to antibiotics
Adriana Rodriguez-Garraus, Maria Alonso-Jáuregui, Amaya Azqueta, Adela López de Cerain
- Abstract
- The increase of antimicrobial resistance is a concerning global health problem. The use of silver has re-emerged as an alternative to antibiotics in form of silver nanoparticles (AgNPs). AgNPs-silica, material composed of AgNPs and silica as carrier, has been developed to be used in animal feed instead of antibiotics. AgNPs-silica safety is being assessed following the EFSA guideline 20181. The in vitro genotoxicity evaluation was designed following the strategy suggested by the EFSA guideline for metallic NPs1, involving the mouse lymphoma assay (MLA) (OECD TG 490) for induction of point mutations and the micronucleus (MN) (OECD TG 487) test for induction of structural and numerical chromosome aberrations. The in vitro comet assay modified by the addition of Fpg was included to provide complementary information on pre-mutagenic DNA damage. Both AgNPs-silica and Ag/AgNPs released from the AgNPs-silica material after agitation in cell culture media, were evaluated at 3 and 24 h treatment. The three in vitro assays were performed without metabolic activation, under good laboratory practices (GLPs). Negative results were obtained from every in vitro assay. Due to the complexity of the AgNPs-silica, an in vivo evaluation is being carried out, following EFSA recommendations. An in vivo integrated strategy has been applied consisting on a repeated dose-28-day oral toxicity study (OECD TG 407) combined with the in vivo mammalian alkaline comet assay (OECD TG 489) and the in vivo mammalian erythrocyte MN test (OECD TG 474), under GLPs-like conditions. Male and female 8-week-old Wistar rats were orally administered with AgNPs-silica, daily, for 28 days at doses of 0, 50, 300 and 2000 mg/kg b.w. Only the females were used for the genotoxicity assays. Samples of liver, spleen, kidney and duodenum were obtained for the alkaline comet assay and bone marrow samples were obtained for the MN test. The preliminary results will be presented in the congress.
- Presented by
- Adriana Rodriguez-Garraus
- Institution
- University of Navarra, Department of Pharmacology and Toxicology



















